TABLE 3

Odds ratios of experiencing food insecurity associated with WFun score and symptoms affecting participants' ability to work

 Age-sex adjustedModel 1bModel 2c
 OR95% CIPOR95% CIPOR95% CIP
Work functioning impairment scale
  7–13Reference   Reference   Reference   
  14–20 (moderately impaired)1.861.432.42<.0011.871.432.43<.0011.711.302.25<.001
  21–35 (severely impaired)3.222.554.06 <.001
<.001a
3.262.584.12 <.001
<.001a
3.012.343.87 <.001
<.001a
Symptoms affecting participants' ability to work
  No problemReference   Reference   Reference   
  Pain-related problems1.450.942.24.0921.420.922.20.1121.120.721.74.623
  Physical movement and mobility3.131.994.94<.0013.232.045.11<.0012.341.463.75<.001
  Fatigue, loss of strength, appetite, fever1.871.192.96.0071.871.182.96.0081.260.792.02.336
  Toileting and defecation1.530.703.33.2821.400.643.06.4021.110.512.44.791
  Mental health problems1.831.272.62.0011.871.302.70.0011.150.781.68.482
  Skin, hair, and cosmetic concerns1.590.823.07.1721.600.823.11.1661.300.662.55.441
  Sleep1.651.112.46.0131.621.082.41.0191.170.771.76.460
  Eye-related matters1.621.012.60.0451.731.072.78.0241.380.852.23.192
  Nasal matters1.650.515.33.4031.620.505.25.4241.310.404.29.654
  Hearing1.050.254.34.9501.050.254.38.9460.820.193.46.783
  Other1.000.581.74.9921.010.581.76.9700.830.471.45.506
 Age-sex adjustedModel 1bModel 2c
 OR95% CIPOR95% CIPOR95% CIP
Work functioning impairment scale
  7–13Reference   Reference   Reference   
  14–20 (moderately impaired)1.861.432.42<.0011.871.432.43<.0011.711.302.25<.001
  21–35 (severely impaired)3.222.554.06 <.001
<.001a
3.262.584.12 <.001
<.001a
3.012.343.87 <.001
<.001a
Symptoms affecting participants' ability to work
  No problemReference   Reference   Reference   
  Pain-related problems1.450.942.24.0921.420.922.20.1121.120.721.74.623
  Physical movement and mobility3.131.994.94<.0013.232.045.11<.0012.341.463.75<.001
  Fatigue, loss of strength, appetite, fever1.871.192.96.0071.871.182.96.0081.260.792.02.336
  Toileting and defecation1.530.703.33.2821.400.643.06.4021.110.512.44.791
  Mental health problems1.831.272.62.0011.871.302.70.0011.150.781.68.482
  Skin, hair, and cosmetic concerns1.590.823.07.1721.600.823.11.1661.300.662.55.441
  Sleep1.651.112.46.0131.621.082.41.0191.170.771.76.460
  Eye-related matters1.621.012.60.0451.731.072.78.0241.380.852.23.192
  Nasal matters1.650.515.33.4031.620.505.25.4241.310.404.29.654
  Hearing1.050.254.34.9501.050.254.38.9460.820.193.46.783
  Other1.000.581.74.9921.010.581.76.9700.830.471.45.506
a

P for trend.

b

The model included age, sex, marital status, job type, income, education, smoking, alcohol consumption, number of employees in the workplace, and the incidence rate of COVID-19 by prefecture at baseline.

c

The model included WFun and symptoms simultaneously, adjusting for age, sex, marital status, job type, income, education, smoking, alcohol consumption, number of employees in the workplace, and the incidence rate of COVID-19 by prefecture at baseline.

TABLE 3

Odds ratios of experiencing food insecurity associated with WFun score and symptoms affecting participants' ability to work

 Age-sex adjustedModel 1bModel 2c
 OR95% CIPOR95% CIPOR95% CIP
Work functioning impairment scale
  7–13Reference   Reference   Reference   
  14–20 (moderately impaired)1.861.432.42<.0011.871.432.43<.0011.711.302.25<.001
  21–35 (severely impaired)3.222.554.06 <.001
<.001a
3.262.584.12 <.001
<.001a
3.012.343.87 <.001
<.001a
Symptoms affecting participants' ability to work
  No problemReference   Reference   Reference   
  Pain-related problems1.450.942.24.0921.420.922.20.1121.120.721.74.623
  Physical movement and mobility3.131.994.94<.0013.232.045.11<.0012.341.463.75<.001
  Fatigue, loss of strength, appetite, fever1.871.192.96.0071.871.182.96.0081.260.792.02.336
  Toileting and defecation1.530.703.33.2821.400.643.06.4021.110.512.44.791
  Mental health problems1.831.272.62.0011.871.302.70.0011.150.781.68.482
  Skin, hair, and cosmetic concerns1.590.823.07.1721.600.823.11.1661.300.662.55.441
  Sleep1.651.112.46.0131.621.082.41.0191.170.771.76.460
  Eye-related matters1.621.012.60.0451.731.072.78.0241.380.852.23.192
  Nasal matters1.650.515.33.4031.620.505.25.4241.310.404.29.654
  Hearing1.050.254.34.9501.050.254.38.9460.820.193.46.783
  Other1.000.581.74.9921.010.581.76.9700.830.471.45.506
 Age-sex adjustedModel 1bModel 2c
 OR95% CIPOR95% CIPOR95% CIP
Work functioning impairment scale
  7–13Reference   Reference   Reference   
  14–20 (moderately impaired)1.861.432.42<.0011.871.432.43<.0011.711.302.25<.001
  21–35 (severely impaired)3.222.554.06 <.001
<.001a
3.262.584.12 <.001
<.001a
3.012.343.87 <.001
<.001a
Symptoms affecting participants' ability to work
  No problemReference   Reference   Reference   
  Pain-related problems1.450.942.24.0921.420.922.20.1121.120.721.74.623
  Physical movement and mobility3.131.994.94<.0013.232.045.11<.0012.341.463.75<.001
  Fatigue, loss of strength, appetite, fever1.871.192.96.0071.871.182.96.0081.260.792.02.336
  Toileting and defecation1.530.703.33.2821.400.643.06.4021.110.512.44.791
  Mental health problems1.831.272.62.0011.871.302.70.0011.150.781.68.482
  Skin, hair, and cosmetic concerns1.590.823.07.1721.600.823.11.1661.300.662.55.441
  Sleep1.651.112.46.0131.621.082.41.0191.170.771.76.460
  Eye-related matters1.621.012.60.0451.731.072.78.0241.380.852.23.192
  Nasal matters1.650.515.33.4031.620.505.25.4241.310.404.29.654
  Hearing1.050.254.34.9501.050.254.38.9460.820.193.46.783
  Other1.000.581.74.9921.010.581.76.9700.830.471.45.506
a

P for trend.

b

The model included age, sex, marital status, job type, income, education, smoking, alcohol consumption, number of employees in the workplace, and the incidence rate of COVID-19 by prefecture at baseline.

c

The model included WFun and symptoms simultaneously, adjusting for age, sex, marital status, job type, income, education, smoking, alcohol consumption, number of employees in the workplace, and the incidence rate of COVID-19 by prefecture at baseline.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close